{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:36:57Z","timestamp":1793140617097,"version":"4.5.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Robust evidence from real-world studies is needed to aid decision-makers and other stakeholders in choosing the best treatment options for patients. The objective of this work was to assess real-world outcomes of treatment strategies for limited- and extensive-stage small cell lung cancer (SCLC) prior to the global introduction of immunotherapies for this disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Searches were conducted in MEDLINE and Embase to identify articles published in English from October 1, 2015, through May 20, 2020. Searches were designed using a combination of Medical Subject Heading (Medline), Emtree (Embase subject headings), and free-text terms such as SCLC. Observational studies reporting data on outcomes of initial treatment strategies in patients with limited- and extensive-stage SCLC were included. Studies with limited sample sizes (&lt;100 patients), enrolled all patients prior to 2010, or did not report outcomes for limited- and extensive-stage SCLC separately were excluded. Data were extracted into a predesigned template by a single researcher. All extractions were validated by a second researcher, with disagreements resolved via consensus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty articles were included in this review. Most enrolled patients from the United States (n = 18 articles) or China (n = 12 articles). Most examined limited-stage (n = 27 articles) SCLC. All studies examined overall survival as the primary outcome. Articles investigating limited-stage SCLC reported outcomes for surgery, chemotherapy and\/or radiotherapy, and adjuvant prophylactic cranial irradiation. In studies examining multiple treatment strategies, chemoradiotherapy was the most commonly utilized therapy (56%\u201382%), with chemotherapy used in 18% to 44% of patients. Across studies, median overall survival was generally higher for chemoradiotherapy (15\u201345 months) compared with chemotherapy alone (6.0\u201315.6 months). Studies of extensive-stage SCLC primarily reported on chemotherapy alone, consolidative thoracic radiotherapy, and radiotherapy for patients presenting with brain metastases. Overall survival was generally lower for patients receiving chemotherapy alone (median: 6.4\u201316.5 months; 3 years, 5%\u201314.9%) compared with chemotherapy in combination with consolidative thoracic radiotherapy (median: 12.1\u201318.0 months; 3 years, 15.0%\u201318.1%). Studies examining whole-brain radiotherapy for brain metastases reported lower median overall survival (5.6\u20138.7 months) compared with stereotactic radiosurgery (10.0\u201314.5 months).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Under current standard of care, which has remained relatively unchanged over the past few decades, prognosis remains poor for patients with SCLC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029783","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:07:49Z","timestamp":1656590869000},"page":"e29783","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["A systematic literature review of real-world treatment outcomes of small cell lung cancer"],"prefix":"10.1097","volume":"101","author":[{"given":"Michael","family":"Stokes","sequence":"first","affiliation":[{"name":"Evidera, Waltham, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noami","family":"Berfeld","sequence":"additional","affiliation":[{"name":"Evidera, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gayle","sequence":"additional","affiliation":[{"name":"AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Descoteaux","sequence":"additional","affiliation":[{"name":"Evidera, Waltham, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Rohrmoser","sequence":"additional","affiliation":[{"name":"AstraZeneca, Gaithersburg, Maryland, United States."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Franks","sequence":"additional","affiliation":[{"name":"AstraZeneca, Gaithersburg, Maryland, United States."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1758834013517413","article-title":"Relapsed small cell lung cancer: treatment options and latest developments.","volume":"6","author":"Asai","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/ijc.27339","article-title":"Cigarette smoking and lung cancer\u2014relative risk estimates for the major histological types from a pooled analysis of case-control studies.","volume":"131","author":"Pesch","year":"2012","journal-title":"Int J Cancer"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: veterans administration lung study group versus international association for the study of lung cancer\u2014what limits limited disease?","volume":"37","author":"Micke","year":"2002","journal-title":"Lung Cancer"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer.","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1200\/JCO.2015.62.4270","article-title":"Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer.","volume":"33","author":"Corso","year":"2015","journal-title":"J Clin Oncol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clon.2017.10.008","article-title":"Population-based results of chemoradiotherapy for limited stage small cell lung cancer in the Netherlands.","volume":"30","author":"Damhuis","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.cllc.2016.11.005","article-title":"Treatment response and prophylactic cranial irradiation are prognostic factors in a real-life limited-disease small-cell lung cancer patient cohort comprehensively staged with cranial magnetic resonance imaging.","volume":"18","author":"Eze","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2016.11.012","article-title":"Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: do all patients benefit?","volume":"122","author":"Farooqi","year":"2017","journal-title":"Radiother Oncol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1759-7714.12262","article-title":"Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer.","volume":"6","author":"Han","year":"2015","journal-title":"Thorac Cancer"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3857\/roj.2019.00318","article-title":"The value of prophylactic cranial irradiation in limited-stage small cell lung cancer: should it always be recommended?","volume":"37","author":"Koh","year":"2019","journal-title":"Radiat Oncol J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/jca.16741","article-title":"Investigating a correlation between chemoradiotherapy schedule parameters and overall survival in a real-life LD SCLC patient cohort.","volume":"7","author":"Manapov","year":"2016","journal-title":"J Cancer"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/jjco\/hyx153","article-title":"Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.","volume":"48","author":"Ohara","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"e174504","DOI":"10.1001\/jamaoncol.2017.4504","article-title":"Barriers to combined-modality therapy for limited-stage small cell lung cancer.","volume":"4","author":"Pezzi","year":"2018","journal-title":"JAMA Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3892\/ol.2016.4231","article-title":"Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer.","volume":"11","author":"Qiu","year":"2016","journal-title":"Oncol Lett"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"811","DOI":"10.21037\/jtd.2019.01.64","article-title":"Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer.","volume":"11","author":"Resio","year":"2019","journal-title":"J Thorac Dis"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/JTO.0000000000000672","article-title":"Utilization of hyperfractionated radiation in small-cell lung cancer and its impact on survival.","volume":"10","author":"Schreiber","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lungcan.2015.01.010","article-title":"Role of surgical resection for patients with limited disease-small cell lung cancer.","volume":"88","author":"Takenaka","year":"2015","journal-title":"Lung Cancer"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jtho.2016.09.133","article-title":"Prophylactic cranial irradiation for patients with surgically resected small cell lung cancer.","volume":"12","author":"Xu","year":"2017","journal-title":"J Thorac Oncol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.7150\/jca.26157","article-title":"Efficacy of surgery and prophylactic cranial irradiation in stage II and III small cell lung cancer.","volume":"9","author":"Yin","year":"2018","journal-title":"J Cancer"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.2147\/CMAR.S222882","article-title":"Comparison of long term results between matched chemoradiotherapy and surgery for limited stage small cell lung cancer.","volume":"11","author":"Chen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00408-017-9992-6","article-title":"Impact of radiation therapy in surgically resected limited-stage small cell lung carcinoma.","volume":"195","author":"Kim","year":"2017","journal-title":"Lung"},{"key":"R34-20250504","first-page":"5","article-title":"Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis.","volume":"38","author":"Jin","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fonc.2020.00626","article-title":"Effects of surgery on survival of early-stage patients with SCLC: propensity score analysis and nomogram construction in SEER database.","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.7150\/jca.31202","article-title":"Benefits of surgery in the multimodality treatment of stage IIB-IIIC small cell lung cancer.","volume":"10","author":"Yang","year":"2019","journal-title":"J Cancer"},{"key":"R37-20250504","first-page":"5203","article-title":"Risk factors associated with brain metastases in patients with limited-stage small-cell lung cancer after prophylactic cranial irradiation.","volume":"10","author":"Lou","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7150\/jca.23583","article-title":"Survival outcomes for patients with surgical and non-surgical treatments in stages I-III small-cell lung cancer.","volume":"9","author":"Che","year":"2018","journal-title":"J Cancer"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.21037\/tcr.2019.12.13","article-title":"Comparison of treatment strategies for patients with limited-stage small cell lung cancer who received chemotherapy.","volume":"9","author":"Wei","year":"2020","journal-title":"Transl Cancer Res"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12957-020-1807-1","article-title":"Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection.","volume":"18","author":"Zhong","year":"2020","journal-title":"World J Surg Oncol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cllc.2016.06.012","article-title":"Effect of accurate staging using positron emission tomography on the outcomes of prophylactic cranial irradiation in patients with limited stage small-cell lung cancer.","volume":"18","author":"Choi","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/fon-2016-0467","article-title":"Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.","volume":"13","author":"An","year":"2017","journal-title":"Future Oncol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-017-2510-0","article-title":"Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.","volume":"134","author":"Bernhardt","year":"2017","journal-title":"J Neurooncol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00066-016-1038-0","article-title":"Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer: a retrospective study.","volume":"192","author":"Chen","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/0284186X.2018.1562207","article-title":"Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.","volume":"58","author":"Jiang","year":"2019","journal-title":"Acta Oncol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.radonc.2017.10.005","article-title":"Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.","volume":"125","author":"Li-Ming","year":"2017","journal-title":"Radiother Oncol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13014-017-0779-y","article-title":"Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?","volume":"12","author":"Luo","year":"2017","journal-title":"Radiat Oncol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13014-020-01509-3","article-title":"Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study.","volume":"15","author":"Ni","year":"2020","journal-title":"Radiat Oncol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jgo.2019.01.017","article-title":"Survival outcomes after whole brain radiotherapy for brain metastases in older adults with newly diagnosed metastatic small cell carcinoma: a national cancer database (NCDB) analysis.","volume":"10","author":"Renz","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2018.03.027","article-title":"Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer.","volume":"120","author":"Robin","year":"2018","journal-title":"Lung Cancer"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cllc.2017.12.003","article-title":"Effect of prophylactic cranial irradiation on overall survival in metastatic small-cell lung cancer: a propensity score-matched analysis.","volume":"19","author":"Sharma","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cllc.2019.06.014","article-title":"Survival outcomes with thoracic radiotherapy in extensive-stage small-cell lung cancer: a propensity score-matched analysis of the national cancer database.","volume":"20","author":"Tian","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1038\/s41598-017-09775-0","article-title":"Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00432-019-03000-3","article-title":"Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.","volume":"145","author":"Zhang","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmir.2019.10.001","article-title":"Should stereotactic radiosurgery be considered for salvage of intracranial recurrence after prophylactic cranial irradiation or whole brain radiotherapy in small cell lung cancer? a population-based analysis and literature review.","volume":"51","author":"Fairchild","year":"2020","journal-title":"J Med Imaging Radiat Sci"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/COC.0000000000000657","article-title":"Real-world adherence to guideline-recommended treatment for small cell lung cancer.","volume":"43","author":"Elegbede","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1759-7714.12943","article-title":"Choice of surgical procedure\u2014lobectomy, segmentectomy, or wedge resection\u2014for patients with stage T1-2N0M0 small cell lung cancer: a population-based study.","volume":"10","author":"Liu","year":"2019","journal-title":"Thorac Cancer"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/1759-7714.13381","article-title":"Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?","volume":"11","author":"Lou","year":"2020","journal-title":"Thorac Cancer"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-5223(19)38975-5","article-title":"Surgical resection in the management of small cell carcinoma of the lung.","volume":"84","author":"Shields","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0022-5223(19)39114-7","article-title":"Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer.","volume":"86","author":"Shepherd","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0003-4975(92)90442-7","article-title":"Results of operation without adjuvant therapy in the treatment of small cell lung cancer.","volume":"54","author":"Shah","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan clinical oncology group study 9104.","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/annonc\/mdj094","article-title":"Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer.","volume":"17","author":"De Ruysscher","year":"2006","journal-title":"Ann Oncol"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.","volume":"22","author":"Fried","year":"2004","journal-title":"J Clin Oncol"},{"key":"R65-20250504","first-page":"49","article-title":"Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes.","volume":"9","author":"Manapov","year":"2018","journal-title":"Lung Cancer (Auckl)"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"vi99","DOI":"10.1093\/annonc\/mdt178","article-title":"Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"24","author":"Fruh","year":"2013","journal-title":"Ann Oncol"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2020.01146","article-title":"Current management and progress in radiotherapy for small cell lung cancer.","volume":"10","author":"Tjong","year":"2020","journal-title":"Front Oncol"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.1999.17.7.2092","article-title":"Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study.","volume":"17","author":"Jeremic","year":"1999","journal-title":"J Clin Oncol"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer.","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"576700","DOI":"10.3389\/fonc.2020.576700","article-title":"Whole brain radiation therapy plus focal radiation boost may generate better survival benefit for brain metastases from non-small cell lung cancer.","volume":"10","author":"Ni","year":"2020","journal-title":"Front Oncol"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13063-018-2745-x","article-title":"Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial.","volume":"19","author":"Bernhardt","year":"2018","journal-title":"Trials"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:09:04Z","timestamp":1746331744000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":63,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029783","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}